Furthermore, LTBR amplification and LMP1 overexpression inactivate TRAF3 activity, thereby inhibiting the innate immune responses for EBV infection through impairment of IRF3 signaling and type I interferon production2,3,23. The gene discussed is IRF3; the disease is Epstein-Barr virus infection.